Dateline City:
KENILWORTH, N.J. & LYON, France
KENILWORTH, N.J. & LYON, France--(BUSINESS WIRE)--Sanofi Pasteur and Merck, known as MSD outside the United States and
Canada, today announced their intent to end their joint vaccines
operations in Europe. Upon concluding their joint venture, both
companies plan to integrate their respective European vaccine businesses
into their operations, independently manage their product portfolios and
pursue their own distinct growth strategies in Europe.
Language:
English
Contact:
MerckMedia:Lainie Keller, 908-236-5036orInvestor:Justin Holko, 908-740-1879orSanofi PasteurMedia:Alain Bernal, +33 4 37 37 50 38orInvestor:Sébastien Martel, +33 1 53 77 45 45
Ticker Slug:
Ticker: MRK Exchange: NYSE
Ticker: SAN Exchange: BOURSE
Ticker: SNY Exchange: NYSE
read more